Published in J Biomed Mater Res on May 01, 1993
A physiologically based pharmacokinetic model for 2,4-toluenediamine leached from polyurethane foam-covered breast implants. Environ Health Perspect (1998) 0.79
TDA release from polyurethane covered breast implants may be a problem. J Biomed Mater Res (1993) 0.75
The nature of the principal type 1 interferon-producing cells in human blood. Science (1999) 10.90
Pressure sores and pressure-decreasing mattresses: controlled clinical trial. Lancet (1994) 3.70
Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med (1972) 3.09
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A (1996) 2.81
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis (2001) 2.51
Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol (1992) 2.50
Immunologic relatedness of papillomaviruses from different species. J Natl Cancer Inst (1980) 2.44
Design of allele-specific inhibitors to probe protein kinase signaling. Curr Biol (1998) 2.36
Imaging findings of extraventricular neurocytoma: report of 3 cases and review of the literature. AJNR Am J Neuroradiol (2008) 2.30
Laparoscopic kidney transplantation: an initial experience. Am J Transplant (2011) 2.24
ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol (2001) 2.14
Arterial embolization is a rapid and effective technique for controlling pelvic fracture hemorrhage. J Trauma (1997) 2.12
Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer (1997) 2.06
Unnatural ligands for engineered proteins: new tools for chemical genetics. Annu Rev Biophys Biomol Struct (2000) 1.99
Human papillomaviruses in women with a history of abnormal Papanicolaou smears and in their male partners. Obstet Gynecol (1987) 1.97
Engineering Src family protein kinases with unnatural nucleotide specificity. Chem Biol (1998) 1.81
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol (1997) 1.80
Human exposure to SV40: review and comment. Am J Epidemiol (1976) 1.77
Specificity of endothelial cell reorientation in response to cyclic mechanical stretching. J Biomech (2001) 1.69
The value to the anesthesia-surgical care team of the preoperative cardiac consultation. J Cardiothorac Anesth (1989) 1.61
Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol (2004) 1.59
Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol (2000) 1.57
Thrombocytopenia and human immunodeficiency virus in children. Pediatrics (1988) 1.49
The oral management of patients who have received radiotherapy to the head and neck region. Br Dent J (2013) 1.46
Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacol Appl Skin Physiol (2003) 1.45
Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience. Ann Oncol (2012) 1.44
Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res (1997) 1.42
Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer (2009) 1.40
Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue. J Biol Chem (2001) 1.39
[Acute compartment syndrome of the foot]. Ned Tijdschr Geneeskd (2004) 1.38
Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol (2006) 1.37
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). Br J Pharmacol (2001) 1.35
Clinical guidelines to diagnose smear-negative pulmonary tuberculosis in Pakistan, a country with low-HIV prevalence. Trop Med Int Health (2006) 1.25
Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J Clin Invest (1986) 1.23
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272. Oncogene (2007) 1.23
A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src. Bioorg Med Chem (1998) 1.23
Genital tract papillomavirus infection in children. Arch Dermatol (1986) 1.21
Key factors in the optimization of paediatric X-ray practice. Br J Radiol (2001) 1.21
Social differences in sexual behaviour and cervical cancer. IARC Sci Publ (1997) 1.20
Specific identification of human papillomavirus type in cervical smears and paraffin sections by in situ hybridization with radioactive probes: a preliminary communication. Int J Gynecol Pathol (1985) 1.19
Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. Cell Immunol (1999) 1.19
A multifaceted study of human papillomavirus and prostate carcinoma. Cancer (1998) 1.18
The cost of juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg (2000) 1.17
Engineering of the myosin-ibeta nucleotide-binding pocket to create selective sensitivity to N(6)-modified ADP analogs. J Biol Chem (1999) 1.14
Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol (2001) 1.14
Surface vs core-tonsillar aerobic and anaerobic flora in recurrent tonsillitis. JAMA (1980) 1.13
Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration. Lupus (2003) 1.13
Electrocardiographic J waves after resuscitation from cardiac arrest. Chest (1990) 1.13
Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol (1999) 1.11
Bacteriology of adenoids and tonsils in children with recurrent adenotonsillitis. Ann Otol Rhinol Laryngol (2001) 1.10
p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol (1993) 1.09
A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope (1992) 1.09
Thanatophoric dwarfism. J Med Genet (1973) 1.06
The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers. Br J Clin Pharmacol (1986) 1.06
Cloning of a cysteine protease required for the molting of Onchocerca volvulus third stage larvae. J Biol Chem (1996) 1.05
Serological investigation of BK papovavirus infection in pregnant women and their offspring. Infect Immun (1980) 1.04
Evaluation of the home-based maternal record: a WHO collaborative study. Bull World Health Organ (1993) 1.04
Serological Investigation of the possibility of congenital transmission of papovavirus JC. Infect Immun (1981) 1.04
Engagement of commissioners, primary and secondary care for developing successful ADHD services. Eur Child Adolesc Psychiatry (2013) 1.03
Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics (1996) 1.02
Lingual dermoid cyst. Otolaryngol Head Neck Surg (1995) 1.02
Human papillomavirus in squamous cell carcinoma, leukoplakia, lichen planus, and clinically normal epithelium of the oral cavity. Ann Otol Rhinol Laryngol (1990) 1.01
Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol (2001) 1.01
Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol (1986) 0.99
Detection of HPV-16 in cell lines and cervical lavage specimens by a polymerase chain reaction-enzyme immunoassay assay. J Med Virol (1992) 0.98
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol (1989) 0.97
Microbiology of healthy and diseased adenoids. Laryngoscope (2000) 0.97
Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis (1998) 0.96
Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet (2001) 0.96
Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors. Oncogene (2012) 0.95
The predominance of human papillomavirus type 16 in vulvar neoplasia. Obstet Gynecol (1988) 0.94
Contemporary management and outcomes for infants born with oesophageal atresia. Br J Surg (2013) 0.93
Aerobic and anaerobic bacteriologic features of serous otitis media in children. Am J Otolaryngol (1984) 0.93
Recurrent respiratory papillomatosis. Clinical overview and management principles. Obstet Gynecol Clin North Am (1987) 0.93
Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit. Sex Transm Dis (1992) 0.92
High prevalence of genital tract papillomavirus infection in female adolescents. Pediatrics (1988) 0.92
Migration and fate of therapeutic stem cells in different brain disease models. Neuroscience (2011) 0.92
Changes in thigh muscle volume predict bone mineral density response to lifestyle therapy in frail, obese older adults. Osteoporos Int (2013) 0.92
Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis. Clin Diagn Lab Immunol (1994) 0.91
Simian virus 40-associated fatal interstitial pneumonia and renal tubular necrosis in a rhesus monkey. J Infect Dis (1980) 0.91
Association of human papillomavirus type 16 with neoplastic lesions of the vulva and other genital sites by in situ hybridization. Am J Pathol (1987) 0.91
N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules. J Control Release (2006) 0.89
Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. Oncogene (2010) 0.89
Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Int J Tuberc Lung Dis (2008) 0.89
Lesch-Nyhan syndrome: a case report. J Indian Soc Pedod Prev Dent (2008) 0.89
The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers. Br J Clin Pharmacol (1986) 0.87
Demonstration of papillomavirus antigen in paraffin sections of laryngeal papillomas. Laryngoscope (1982) 0.87
Esophageal cryptosporidiosis in a child with acquired immune deficiency syndrome. Gastroenterology (1986) 0.86
A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas. Br J Cancer (1997) 0.86
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3. J Gen Virol (2011) 0.86
Risk assessment for surgical site infections following total hip and total knee prostheses. J Chemother (2001) 0.85
Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg (1991) 0.85
Human papillomavirus genotypes associated with cervical neoplasia in India. Int J Gynecol Cancer (2006) 0.85
Topographic study of cervical condyloma and intraepithelial neoplasia. Cancer (1987) 0.85
Src-Abl tyrosine kinase chimeras: replacement of the adenine binding pocket of c-Abl with v-Src to swap nucleotide and inhibitor specificities. Biochemistry (2000) 0.85
Malignant hyperthermia associated with isoflurane anesthesia. Anesth Analg (1982) 0.84
Phage-display evolution of tyrosine kinases with altered nucleotide specificity. Biopolymers (2001) 0.84
Group A beta-hemolytic Streptococcus and Waterhouse-Friderichsen syndrome. Pediatr Infect Dis J (1992) 0.83
Human 15-lipoxygenase gene promoter: analysis and identification of DNA binding sites for IL-13-induced regulatory factors in monocytes. Mol Biol Rep (1998) 0.83